Cover Image
市場調查報告書

人工心血管置換設備:醫療設備的開發平台評估

Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 350920
出版日期 內容資訊 英文 187 Pages
訂單完成後即時交付
價格
Back to Top
人工心血管置換設備:醫療設備的開發平台評估 Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015
出版日期: 2016年01月01日 內容資訊: 英文 187 Pages
簡介

本報告提供人工心血管置換設備的開發中產品調查分析,以各開發階段比較分析為焦點,提供您正在開發開發中產品的主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 人工心血管置換設備概要

第3章 開發中的產品

  • 人工心血管置換設備 - 開發中產品:各開發階段
  • 人工心血管置換設備 - 開發中產品:各市場區隔
  • 人工心血管置換設備 - 開發中產品:各地區
  • 人工心血管置換設備 - 開發中產品:法規別
  • 人工心血管置換設備 - 開發中產品:核准預定日別
  • 人工心血管置換設備 - 進行中的臨床試驗

第4章 人工心血管置換設備 - 正在開發的開發中產品:各企業

  • 人工心血管置換設備企業 - 開發中產品:各開發階段
  • 人工心血管置換設備 - 開發中產品:各開發階段

第5章 人工心血管置換設備企業與產品概要

  • 4tech Cardio Ireland Limited
  • Agamit Medical Ltd.
  • Ample Medical Inc.
  • Amsel Medical Corporation
  • Aporo Biomedical, Inc.
  • Arbor Surgical Technologies, Inc.
  • BioStable Science & Engineering, Inc.
  • BioVentrix, Inc.
  • CARAG AG
  • Cardica, Inc.
  • Cardiosolutions, Inc.
  • Cardious, Inc.
  • Celyad SA
  • Children's Hospital Boston
  • Cierra, Inc. (暫停中)
  • CoAptus Medical Corporation
  • CollPlant Ltd.
  • coramaze technologies GmbH
  • Cordis Corporation
  • Coroneo Inc.等

第6章 人工心血管置換設備 - 最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0139EPD

GlobalData's Medical Devices sector report, "Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiovascular Prosthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Prosthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Prosthetic Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Prosthetic Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Prosthetic Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cardiovascular Prosthetic Devices Overview

3. Products under Development

  • 3.1. Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
  • 3.2. Cardiovascular Prosthetic Devices - Pipeline Products by Segment
  • 3.3. Cardiovascular Prosthetic Devices - Pipeline Products by Territory
  • 3.4. Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path
  • 3.5. Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date
  • 3.6. Cardiovascular Prosthetic Devices - Ongoing Clinical Trials

4. Cardiovascular Prosthetic Devices - Pipeline Products under Development by Companies

  • 4.1. Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development
  • 4.2. Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development

5. Cardiovascular Prosthetic Devices Companies and Product Overview

  • 5.1. 4tech Cardio Ireland Limited Company Overview
    • 5.1.1. 4tech Cardio Ireland Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Agamit Medical Ltd. Company Overview
    • 5.2.1. Agamit Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Ample Medical Inc. Company Overview
    • 5.3.1. Ample Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Amsel Medical Corporation Company Overview
    • 5.4.1. Amsel Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Aporo Biomedical, Inc. Company Overview
    • 5.5.1. Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Arbor Surgical Technologies, Inc. Company Overview
    • 5.6.1. Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BioStable Science & Engineering, Inc. Company Overview
    • 5.7.1. BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. BioVentrix, Inc. Company Overview
    • 5.8.1. BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. CARAG AG Company Overview
    • 5.9.1. CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Cardica, Inc. Company Overview
    • 5.10.1. Cardica, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Cardiosolutions, Inc. Company Overview
    • 5.11.1. Cardiosolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Cardious, Inc. Company Overview
    • 5.12.1. Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Celyad SA Company Overview
    • 5.13.1. Celyad SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Children's Hospital Boston Company Overview
    • 5.14.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Cierra, Inc. (Inactive) Company Overview
    • 5.15.1. Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. CoAptus Medical Corporation Company Overview
    • 5.16.1. CoAptus Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. CollPlant Ltd. Company Overview
    • 5.17.1. CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. coramaze technologies GmbH Company Overview
    • 5.18.1. coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Cordis Corporation Company Overview
    • 5.19.1. Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Coroneo Inc. Company Overview
    • 5.20.1. Coroneo Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. CUBE SRL Company Overview
    • 5.21.1. CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Edwards Lifesciences Corporation Company Overview
    • 5.22.1. Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Emory University Company Overview
    • 5.23.1. Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Guided Delivery Systems, Inc. Company Overview
    • 5.24.1. Guided Delivery Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Instituto de investigacion sanitaria Marques de Valdecilla Company Overview
    • 5.25.1. Instituto de investigacion sanitaria Marques de Valdecilla Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. IPI Singapore Company Overview
    • 5.26.1. IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Kardium Inc. Company Overview
    • 5.27.1. Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Lartim Medical Ltd Company Overview
    • 5.28.1. Lartim Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview
    • 5.29.1. Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Mardil Medical, Inc. Company Overview
    • 5.30.1. Mardil Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Mayo Clinic. Company Overview
    • 5.31.1. Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Medtentia AB Company Overview
    • 5.32.1. Medtentia AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. MiCardia Corporation Company Overview
    • 5.33.1. MiCardia Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Michigan Critical Care Consultants, Inc. Company Overview
    • 5.34.1. Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Middle Peak Medical, Inc Company Overview
    • 5.35.1. Middle Peak Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Millipede, LLC Company Overview
    • 5.36.1. Millipede, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Mitral Heal Company Overview
    • 5.37.1. Mitral Heal Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Mitralign, Inc. Company Overview
    • 5.38.1. Mitralign, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Mitralix Ltd. Company Overview
    • 5.39.1. Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Mitre Medical Corp. Company Overview
    • 5.40.1. Mitre Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. MValve Technologies Ltd. Company Overview
    • 5.41.1. MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Neochord, Inc. Company Overview
    • 5.42.1. Neochord, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Occlutech International AB Company Overview
    • 5.43.1. Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Phoenix Cardiac Devices, Inc. Company Overview
    • 5.44.1. Phoenix Cardiac Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. QuantumCor Inc. (Inactive) Company Overview
    • 5.45.1. QuantumCor Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. ReCor Medical, Inc. Company Overview
    • 5.46.1. ReCor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. SCR, Inc. Company Overview
    • 5.47.1. SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. SeptRx, Inc. Company Overview
    • 5.48.1. SeptRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Sorin S.p.A. (Inactive) Company Overview
    • 5.49.1. Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. St. Jude Medical, Inc. Company Overview
    • 5.50.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Sutura, Inc. (Inactive) Company Overview
    • 5.51.1. Sutura, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Swissimplant AG (Inactive) Company Overview
    • 5.52.1. Swissimplant AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. The Tel Aviv Sourasky Medical Center Company Overview
    • 5.53.1. The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. TransCardiac Therapeutics, LLC Company Overview
    • 5.54.1. TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. Trinity College Dublin Company Overview
    • 5.55.1. Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. University of Minnesota Company Overview
    • 5.56.1. University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. Valcare Medical Company Overview
    • 5.57.1. Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. Valtech Cardio Ltd. Company Overview
    • 5.58.1. Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. Viacor, Inc. Company Overview
    • 5.59.1. Viacor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. Vir(Sn), Inc. Company Overview
    • 5.60.1. Vir(Sn), Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. W. L. Gore & Associates, Inc. Company Overview
    • 5.61.1. W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Cardiovascular Prosthetic Devices- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
  • Table 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment
  • Table 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory
  • Table 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path
  • Table 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials
  • Table 7: Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
  • Table 9: 4tech Cardio Ireland Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: TriCinch System - Product Status
  • Table 11: TriCinch System - Product Description
  • Table 12: Agamit Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Device For Mitral Valve Repair - Product Status
  • Table 14: Device For Mitral Valve Repair - Product Description
  • Table 15: Ample Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: PS3 System - Product Status
  • Table 17: PS3 System - Product Description
  • Table 18: Amsel Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Amsel Occluder Device - Percutaneous Procedures - Product Status
  • Table 20: Amsel Occluder Device - Percutaneous Procedures - Product Description
  • Table 21: Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Patent Foramen Ovale Closure Device - Product Status
  • Table 23: Patent Foramen Ovale Closure Device - Product Description
  • Table 24: Aporo Biomedical, Inc. - Ongoing Clinical Trials Overview
  • Table 25: Patent Foramen Ovale Closure Device - Prospective Clinical Follow-up of Patients Presenting With Cryptogenic Stroke Treated With the Percutaneous Closure of a Patent Foramen Ovale
  • Table 26: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Trilogy Attachment Clip - Product Status
  • Table 28: Trilogy Attachment Clip - Product Description
  • Table 29: BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: HAART 200 Annuloplasty Device - Product Status
  • Table 31: HAART 200 Annuloplasty Device - Product Description
  • Table 32: HAART 300 Annuloplasty Device - Product Status
  • Table 33: HAART 300 Annuloplasty Device - Product Description
  • Table 34: BioStable Science & Engineering, Inc. - Ongoing Clinical Trials Overview
  • Table 35: HAART 200 Annuloplasty Device - HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction
  • Table 36: BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Revivent-TC System - Product Status
  • Table 38: Revivent-TC System - Product Description
  • Table 39: BioVentrix, Inc. - Ongoing Clinical Trials Overview
  • Table 40: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy
  • Table 41: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Solysafe Septal Occluder - Degradable Version - Product Status
  • Table 43: Solysafe Septal Occluder - Degradable Version - Product Description
  • Table 44: Cardica, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Cardica Mitral Repair - Product Status
  • Table 46: Cardica Mitral Repair - Product Description
  • Table 47: PFO Closure Device - Product Status
  • Table 48: PFO Closure Device - Product Description
  • Table 49: Cardiosolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Mitra-Spacer - Product Status
  • Table 51: Mitra-Spacer - Product Description
  • Table 52: Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: AvA Aortic Valve Bypass Graft System - Product Status
  • Table 54: AvA Aortic Valve Bypass Graft System - Product Description
  • Table 55: Celyad SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Cardiao3 Closure Device - Product Status
  • Table 57: Cardiao3 Closure Device - Product Description
  • Table 58: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Endovascular Prosthesis - Product Status
  • Table 60: Endovascular Prosthesis - Product Description
  • Table 61: Mitral Valve Repair Clip - Product Status
  • Table 62: Mitral Valve Repair Clip - Product Description
  • Table 63: Tricuspid Valve Repair Device - Product Status
  • Table 64: Tricuspid Valve Repair Device - Product Description
  • Table 65: Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: PFx Closure System - Product Status
  • Table 67: PFx Closure System - Product Description
  • Table 68: CoAptus Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Non-Implant Therapeutic Catheter Device - Product Status
  • Table 70: Non-Implant Therapeutic Catheter Device - Product Description
  • Table 71: CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: VergenixHVR - Product Status
  • Table 73: VergenixHVR - Product Description
  • Table 74: coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 75: Mitramaze Valve Repair System - Product Status
  • Table 76: Mitramaze Valve Repair System - Product Description
  • Table 77: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: SeptRx PFO - Product Status
  • Table 79: SeptRx PFO - Product Description
  • Table 80: Coroneo Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: Extra-Aortic Annuloplasty Ring - Product Status
  • Table 82: Extra-Aortic Annuloplasty Ring - Product Description
  • Table 83: CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Mitral-FERCube Ring - Product Status
  • Table 85: Mitral-FERCube Ring - Product Description
  • Table 86: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Coapsys - Product Status
  • Table 88: Coapsys - Product Description
  • Table 89: FORMA Tricuspid Repair System - Product Status
  • Table 90: FORMA Tricuspid Repair System - Product Description
  • Table 91: MOBIUS Leaflet Repair System - Product Status
  • Table 92: MOBIUS Leaflet Repair System - Product Description
  • Table 93: MONARC Mitral Repair System - Product Status
  • Table 94: MONARC Mitral Repair System - Product Description
  • Table 95: Edwards Lifesciences Corporation - Ongoing Clinical Trials Overview
  • Table 96: Coapsys - Valvular And Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
  • Table 97: Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: MitraPlug - Product Status
  • Table 99: MitraPlug - Product Description
  • Table 100: MitraSurg - Product Status
  • Table 101: MitraSurg - Product Description
  • Table 102: Guided Delivery Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: GDS Accucinch System - Product Status
  • Table 104: GDS Accucinch System - Product Description
  • Table 105: Guided Delivery Systems, Inc. - Ongoing Clinical Trials Overview
  • Table 106: GDS Accucinch System - A Study of Percutaneous Left Ventricular Reshaping of Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve LV Function Using the Accucinch System
  • Table 107: GDS Accucinch System - Clinical Protocol - A Feasibility Study Using the Accucinch System in the Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function
  • Table 108: Instituto de investigacion sanitaria Marques de Valdecilla Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: Myocardial Bioactive Implant - Product Status
  • Table 110: Myocardial Bioactive Implant - Product Description
  • Table 111: IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: PFO Occluder - Product Status
  • Table 113: PFO Occluder - Product Description
  • Table 114: Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: Percutaneous Mitral Valve Regurgitation Device - Product Status
  • Table 116: Percutaneous Mitral Valve Regurgitation Device - Product Description
  • Table 117: Lartim Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 118: Mitral Valve Repair Device - Product Status
  • Table 119: Mitral Valve Repair Device - Product Description
  • Table 120: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Absorbable Occluder - Product Status

List of Figures

  • Figure 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
  • Figure 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment
  • Figure 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory
  • Figure 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path
  • Figure 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials
Back to Top